88 related articles for article (PubMed ID: 33925109)
1. Radiation-Induced Metabolic Shifts in the Hepatic Parenchyma: Findings from
Chung YH; Tsai CK; Yu CF; Wang WL; Yang CL; Hong JH; Yen TC; Chen FH; Lin G
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925109
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the [
Brasse D; Burckel H; Marchand P; Rousseau M; Ouadi A; Vanstalle M; Finck C; Laquerriere P; Boisson F
Mol Imaging Biol; 2021 Oct; 23(5):724-732. PubMed ID: 33847900
[TBL] [Abstract][Full Text] [Related]
3. Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
Yamashige D; Kawamura Y; Kobayashi M; Shindoh J; Kobayashi Y; Okubo S; Muraishi N; Kajiwara A; Iritani S; Fujiyama S; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Arase Y; Hashimoto M; Kumada H
Oncology; 2021; 99(3):169-176. PubMed ID: 33207358
[TBL] [Abstract][Full Text] [Related]
4. 1H-NMR-based metabolomics reveals the biomarker panel and molecular mechanism of hepatocellular carcinoma progression.
Wang KX; Du GH; Qin XM; Gao L
Anal Bioanal Chem; 2022 Feb; 414(4):1525-1537. PubMed ID: 35024914
[TBL] [Abstract][Full Text] [Related]
5. Liver: glucose metabolism and 18F-fluorodeoxyglucose PET findings in normal parenchyma and diseases.
Sarikaya I; Schierz JH; Sarikaya A
Am J Nucl Med Mol Imaging; 2021; 11(4):233-249. PubMed ID: 34513277
[TBL] [Abstract][Full Text] [Related]
6. Investigating the attenuating effect of telmisartan against radiation-induced intestinal injury using
Fooladi M; Shirazi A; Sheikhzadeh P; Amirrashedi M; Ghahramani F; Cheki M; Khoobi M
Int J Radiat Biol; 2023; 99(3):446-458. PubMed ID: 35930426
[TBL] [Abstract][Full Text] [Related]
7. A statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study.
Assi N; Fages A; Vineis P; Chadeau-Hyam M; Stepien M; Duarte-Salles T; Byrnes G; Boumaza H; Knüppel S; Kühn T; Palli D; Bamia C; Boshuizen H; Bonet C; Overvad K; Johansson M; Travis R; Gunter MJ; Lund E; Dossus L; Elena-Herrmann B; Riboli E; Jenab M; Viallon V; Ferrari P
Mutagenesis; 2015 Nov; 30(6):743-53. PubMed ID: 26130468
[TBL] [Abstract][Full Text] [Related]
8. Operando NMR metabolomics of a microfluidic cell culture.
Rogers G; Barker S; Sharma M; Khakoo S; Utz M
J Magn Reson; 2023 Apr; 349():107405. PubMed ID: 36842430
[TBL] [Abstract][Full Text] [Related]
9. Glycolytic Plasticity of Metastatic Lung Cancer Captured by Noninvasive
Chung YH; Hung TH; Yu CF; Tsai CK; Weng CC; Jhang F; Chen FH; Lin G
Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677035
[TBL] [Abstract][Full Text] [Related]
10. Microbiome and Metabolomics in Liver Cancer: Scientific Technology.
Ganesan R; Yoon SJ; Suk KT
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613980
[TBL] [Abstract][Full Text] [Related]
11. Urine NMR Metabolomics for Precision Oncology in Colorectal Cancer.
Brezmes J; Llambrich M; Cumeras R; Gumà J
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232473
[TBL] [Abstract][Full Text] [Related]
12. Untargeted metabolomics analysis identifies creatine, myo-inositol, and lipid pathway modulation in a murine model of tendinopathy.
Sikes KJ; McConnell A; Serkova N; Cole B; Frisbie D
J Orthop Res; 2022 Apr; 40(4):965-976. PubMed ID: 34081345
[TBL] [Abstract][Full Text] [Related]
13. Role of metabolomics in identifying cardiac hypertrophy: an overview of the past 20 years of development and future perspective.
Singh SP; Sethi R; Saxena SK; Gupta A
Expert Rev Mol Med; 2021 Aug; 23():e8. PubMed ID: 34376261
[TBL] [Abstract][Full Text] [Related]
14. Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study.
Gaglio D; Valtorta S; Ripamonti M; Bonanomi M; Damiani C; Todde S; Negri AS; Sanvito F; Mastroianni F; Di Campli A; Turacchio G; Di Grigoli G; Belloli S; Luini A; Gilardi MC; Colangelo AM; Alberghina L; Moresco RM
Oncotarget; 2016 Aug; 7(32):52017-52031. PubMed ID: 27409831
[TBL] [Abstract][Full Text] [Related]
15. iMSEA: A Novel Metabolite Set Enrichment Analysis Strategy to Decipher Drug Interactions.
Wang Y; Liu X; Dong L; Cheng KK; Lin C; Wang X; Dong J; Deng L; Raftery D
Anal Chem; 2023 Apr; 95(15):6203-6211. PubMed ID: 37023366
[TBL] [Abstract][Full Text] [Related]
16. Aspartate and Acetate Fuel Gastrointestinal Stromal Tumors Beyond the Warburg Effect.
Lai YC; Lin G; Ho KC; Lu KY; Tsai CK; Hung CY; Yeh TS
Ann Surg Open; 2022 Dec; 3(4):e224. PubMed ID: 37600289
[TBL] [Abstract][Full Text] [Related]
17. Ketohexokinase-mediated fructose metabolism is lost in hepatocellular carcinoma and can be leveraged for metabolic imaging.
Tee SS; Kim N; Cullen Q; Eskandari R; Mamakhanyan A; Srouji RM; Chirayil R; Jeong S; Shakiba M; Kastenhuber ER; Chen S; Sigel C; Lowe SW; Jarnagin WR; Thompson CB; Schietinger A; Keshari KR
Sci Adv; 2022 Apr; 8(14):eabm7985. PubMed ID: 35385296
[TBL] [Abstract][Full Text] [Related]
18. Bitter melon juice-intake modulates glucose metabolism and lactate efflux in tumors in its efficacy against pancreatic cancer.
Dhar D; Raina K; Kant R; Wempe MF; Serkova NJ; Agarwal C; Agarwal R
Carcinogenesis; 2019 Sep; 40(9):1164-1176. PubMed ID: 31194859
[TBL] [Abstract][Full Text] [Related]
19. Profiling Carbohydrate Metabolism in Liver and Hepatocellular Carcinoma with [
Chen J; LaGue E; Li J; Yang C; Hackett EP; Mendoza M; Alger JR; DeBerardinis RJ; Corbin IR; Billingsley KL; Park JM
Anal Sens; 2021 Nov; 1(4):196-202. PubMed ID: 35693130
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and Metabolomic Changes after Electromagnetic Hyperthermia Exposure to Treat Colorectal Cancer Liver Implants in Rats.
Herrero de la Parte B; Irazola M; Pérez-Muñoz J; Rodrigo I; Iturrizaga Correcher S; Mar Medina C; Castro K; Etxebarria N; Plazaola F; García JÁ; García-Alonso I; Echevarría-Uraga JJ
Nanomaterials (Basel); 2021 May; 11(5):. PubMed ID: 34067780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
